Mathijs Bunck
Sr. Medical Director, Product Development (Late Phase Clinical R&D), Lilly Diabetes @ Eli Lilly and Company
About Mathijs Bunck
Mathijs Bunck serves as the Senior Medical Director for Product Development in Late Phase Clinical R&D at Eli Lilly and Company, focusing on diabetes treatment and related conditions. He has extensive experience in clinical research and has held various roles in endocrinology and internal medicine across multiple institutions in the Netherlands and the United States.